99.74
前日終値:
$98.56
開ける:
$98.19
24時間の取引高:
10.33M
Relative Volume:
1.29
時価総額:
$151.04B
収益:
$17.55B
当期純損益:
$2.03B
株価収益率:
72.80
EPS:
1.37
ネットキャッシュフロー:
$2.72B
1週間 パフォーマンス:
-2.30%
1か月 パフォーマンス:
-3.12%
6か月 パフォーマンス:
+10.69%
1年 パフォーマンス:
+29.60%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
99.74 | 151.04B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
ABT
Abbott Laboratories
|
135.62 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
SYK
Stryker Corp
|
377.30 | 146.71B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
87.27 | 112.09B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
75.15 | 45.47B | 5.54B | 4.18B | 623.10M | 7.00 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-04-16 | アップグレード | Needham | Hold → Buy |
2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
2024-10-18 | ダウングレード | Needham | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-06-30 | 開始されました | CL King | Buy |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Buy |
2022-12-22 | 開始されました | Mizuho | Neutral |
2022-12-20 | 再開されました | Citigroup | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-06 | 開始されました | Wolfe Research | Outperform |
2022-05-27 | アップグレード | Needham | Hold → Buy |
2022-04-13 | 再開されました | Truist | Buy |
2022-03-02 | 再開されました | BofA Securities | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-05-26 | ダウングレード | Needham | Buy → Hold |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Overweight |
2020-09-17 | 開始されました | Truist | Buy |
2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | アップグレード | Goldman | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Buy |
2019-12-30 | 繰り返されました | Cowen | Outperform |
2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
2019-09-05 | 再開されました | JP Morgan | Overweight |
2019-09-03 | 再開されました | Barclays | Overweight |
2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
2018-11-28 | 開始されました | UBS | Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
2018-09-07 | 繰り返されました | Needham | Strong Buy |
2018-09-04 | アップグレード | Jefferies | Hold → Buy |
2018-07-06 | 繰り返されました | Needham | Strong Buy |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Why the Market Dipped But Boston Scientific (BSX) Gained Today - Nasdaq
Boston Scientific Shares Rally Over 1%, Highlighting Strong Long-Term Growth - Daily Chhattisgarh News
BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth? - Yahoo Finance
What's the secret behind Boston Sci's successful product launches? - BioWorld MedTech
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029 - GlobeNewswire Inc.
Five things: The Newbury GM, Zoominfo cuts, Vertex, Boston Scientific and casino night - The Business Journals
Boston Scientific to sell 24-acre campus in Minnetonka - Finance & Commerce
Boston Scientific is selling a Minnesota campus - MassDevice
Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock - The Globe and Mail
Boston Scientific lists 24-acre Minnesota campus for sale ahead of Maple Grove move - The Business Journals
How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - MSN
Boston Scientific lists 24-acre Minnetonka campus for sale ahead of Maple Grove move - The Business Journals
Boston Scientific Stock Slips Over 1% Amid Short-Term Pullback - Daily Chhattisgarh News
Boston Scientific (BSX) Upgraded to Buy: Here's Why - Yahoo Finance
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Wall Street Bulls Look Optimistic About Boston Scientific (BSX): Should You Buy? - Yahoo Finance
Boston Scientific’s EVP sells $5.8 million in stock By Investing.com - Investing.com Nigeria
Boston Scientific’s EVP sells $5.8 million in stock - Investing.com
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
Boston Scientific (NYSE:BSX) Secures US$30-45 Million Deal with Bittium for ECG Devices - Yahoo Finance
Emerging Markets Power Boston Scientific: Will The Growth Trend Continue? - Barchart.com
Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance
Emerging Markets Power Boston Scientific: Will the Growth Trend Continue? - Yahoo Finance
How Is Boston Scientific's Stock Performance Compared To Other Medical Device Stocks? - Barchart.com
Rising obesity levels spur endoscopic sleeve uptick - BioWorld MedTech
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Boston Scientific’s longtime DEI, HR leader exits for chief HR role at new company - MassDevice
Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scienti - GuruFocus
Before the Bell-Boston Scientific drops on profit miss - Reuters
Insider Sell: Edward Ludwig Sells 4,000 Shares of Boston Scientific Corp (BSX) - GuruFocus
Piper Sandler maintains Boston Scientific stock at Overweight - Investing.com
Michael Mahoney Turned Boston Scientific Into A Medical Tech Empire - Investor's Business Daily
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook - Benzinga
Boston Scientific ends TAVR sales; J&J shares Monarch robot data - MedTech Dive
Boston Scientific (BSX) Ends Acurate TAVR Program, Shifts Focus to Promising Projects | BSX Stock News - GuruFocus
BSX: Analyst Reiterates Buy Rating for Boston Scientific | BSX S - GuruFocus
In TAVR setback, Boston Sci pulls plug on Acurate valves - BioWorld MedTech
Boston Scientific discontinues Acurate TAVR sales, cites regulatory burden - MassDevice
Boston Scientific Ends ACURATE Valve Sales By Investing.com - Investing.com Canada
Evercore ISI maintains Boston Scientific stock at Outperform - Investing.com
TD Cowen maintains Boston Scientific stock at $115 target By Investing.com - Investing.com South Africa
TD Cowen maintains Boston Scientific stock at $115 target - Investing.com
Boston Scientific (BSX) Discontinues Sales of ACURATE Aortic Valve Systems - GuruFocus
Boston Scientific (BSX) Discontinues Valve Product Amid Regulato - GuruFocus
JPMorgan maintains Boston Scientific stock with $135 target - Investing.com
Citi maintains Buy on Boston Scientific, keeps $125 target - Investing.com
Needham sees Boston Scientific stock as a buy, target at $115 - Investing.com
Boston Scientific (BSX) Discontinues Valve Product Amid Regulatory Challenges | BSX Stock News - GuruFocus
Boston Scientific (BSX) Halts Aortic Valve Systems, Boosting Com - GuruFocus
Boston Scientific (BSX) Halts Global Sales of ACURATE Valve Syst - GuruFocus
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):